日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery

膀胱癌手术前每周服用厄洛替尼的II期临床化学预防试验

Downs, Tracy M; Bailey, Howard H; Lozar, Taja; Schmitz, Natalie S; Green, Heather; Scarlett, Cameron O; Havighurst, Thomas C; Twaroski, Kyleigh; DeShong, Katina; Wollmer, Barbara; Bivalacqua, Trinity J; Saltzstein, Daniel R; Shore, Neal; Kim, KyungMann; Huang, Wei; Ricke, William A; Barroilhet, Lisa; House, Margaret; Parnes, Howard L; Messing, Edward

A phase I study of intra-anal artesunate (suppositories) to treat anal high-grade squamous intraepithelial lesions

一项关于肛门内使用青蒿琥酯(栓剂)治疗肛门高级别鳞状上皮内病变的I期研究

Fang, Sandy Hwang; Plesa, Mihaela; Carchman, Evie H; Cowell, Nicole A; Staudt, Emily; Twaroski, Kyleigh Ann; Buchwald, Ulrike K; Trimble, Cornelia L

Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa

隐性营养不良性大疱性表皮松解症中的回复镶嵌成纤维细胞

K Twaroski, C Eide, M J Riddle, L Xia, C J Lees, W Chen, W Mathews, D R Keene, J A McGrath, J Tolar

Correction: Rapid DNA replication origin licensing protects stem cell pluripotency

更正:快速 DNA 复制起点许可保护干细胞多能性

Jacob Peter Matson, Raluca Dumitru, Philip Coryell, Ryan M Baxley, Weili Chen, Kirk Twaroski, Beau R Webber, Jakub Tolar, Anja-Katrin Bielinsky, Jeremy E Purvis, Jeanette Gowen Cook

ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism

ATXN1-CIC复合物通过功能获得机制,是1型脊髓小脑性共济失调中小脑病理的主要驱动因素。

Maxime W C Rousseaux ,Tyler Tschumperlin ,Hsiang-Chih Lu ,Elizabeth P Lackey ,Vitaliy V Bondar ,Ying-Wooi Wan ,Qiumin Tan ,Carolyn J Adamski ,Jillian Friedrich ,Kirk Twaroski ,Weili Chen ,Jakub Tolar ,Christine Henzler ,Ajay Sharma ,Aleksandar Bajić ,Tao Lin ,Lisa Duvick ,Zhandong Liu ,Roy V Sillitoe ,Huda Y Zoghbi ,Harry T Orr

HNF4A Regulates the Formation of Hepatic Progenitor Cells from Human iPSC-Derived Endoderm by Facilitating Efficient Recruitment of RNA Pol II

HNF4A 通过促进 RNA Pol II 的有效募集来调节人类 iPSC 衍生内胚层中肝祖细胞的形成

Ann DeLaForest, Francesca Di Furio, Ran Jing, Amy Ludwig-Kubinski, Kirk Twaroski, Amanda Urick, Kirthi Pulakanti, Sridhar Rao, Stephen A Duncan

Rapid DNA replication origin licensing protects stem cell pluripotency

快速DNA复制起点许可保护干细胞多能性

Jacob Peter Matson, Raluca Dumitru, Philip Coryell, Ryan M Baxley, Weili Chen, Kirk Twaroski, Beau R Webber, Jakub Tolar, Anja-Katrin Bielinsky, Jeremy E Purvis, Jeanette Gowen Cook

Feeder-Free Derivation of Naive Human Pluripotent Stem Cells

无饲养层衍生原始人类多能干细胞

Emily Ward, Kirk Twaroski, Jakub Tolar

CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa

基于 CRISPR/Cas9 的隐性营养不良型大疱性表皮松解症的基因校正

Beau R Webber #, Mark J Osborn #, Amber N McElroy, Kirk Twaroski, Cara-Lin Lonetree, Anthony P DeFeo, Lily Xia, Cindy Eide, Christopher J Lees, Ron T McElmurry, Megan J Riddle, Chong Jai Kim, Dharmeshkumar D Patel, Bruce R Blazar, Jakub Tolar

Mapping the Cell-Surface N-Glycoproteome of Human Hepatocytes Reveals Markers for Selecting a Homogeneous Population of iPSC-Derived Hepatocytes

绘制人类肝细胞的细胞表面 N-糖蛋白质组图谱可揭示用于选择 iPSC 衍生肝细胞的均质群体的标记

Sunil K Mallanna, Max A Cayo, Kirk Twaroski, Rebekah L Gundry, Stephen A Duncan